SYC-522

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameSYC-522
Drug Alias NameSYC-522
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDOT1 like histone lysine methyltransferase inhibitors
TargetsDOT1 like histone lysine methyltransferase
Therapy Area/IndicationsPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBaylor College Of Medicine
China Registration ClassN/A

Develop Information

Active CompaniesBaylor College Of Medicine
Inactive CompaniesN/A
Active IndicationsPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A